At a glance
ClinicalIndex Comparison RecordN/ACompleted· 26 enrolled
Drug / intervention
Novel ROTEM interpretation softwaredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effectiveness of a Novel Software Program to Help in ROTEM Interpretation
In Brief
A clinical study evaluating Novel ROTEM interpretation software for Coagulation Disorder, Blood. Completed, enrolled 26 participants across 1 site.
Detailed Summary
The purpose of this study is to assess a novel rotational thromboelastometry (ROTEM®) interpretation software to determine whether its use improves the accuracy of clinician interpretation.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCoagulation Disorder, Blood
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
First PostedOct 2022
Enrollment StartApr 2023
Primary CompletionDec 2024
TodayJul 2026
First PostedOct 21, 2022
Enrollment StartApr 13, 2023
Primary CompletionDec 31, 2024
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 3.7 years ago
Interventions
Novel ROTEM interpretation softwaredevice
Clinicians will be asked to interpret ROTEM studies before and after exposure to a novel ROTEM interpretation software.